CDLX logo

Cardlytics Inc. (CDLX)

$0.85

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CDLX

Market cap

$46202132

EPS

-2.16

P/E ratio

--

Price to sales

0.2

Dividend yield

--

Beta

1.04615

Price on CDLX

Previous close

$0.91

Today's open

$0.91

Day's range

$0.84 - $0.91

52 week range

$0.80 - $3.28

Profile about CDLX

CEO

Amit Gupta

Employees

454

Headquarters

Atlanta, GA

Exchange

NASDAQ Global Market

Shares outstanding

54056548

Issue type

Common Stock

CDLX industries and sectors

Media

Traditional Media

News on CDLX

Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2025 Earnings Release

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the fourth quarter and full year ending December 31, 2025 will be released on March 4, 2026, after market close. Conference Call Details: When: March 4, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be.

news source

Business Wire • Feb 19, 2026

news preview

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on January 12, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 1,000,000 restricted stock units of Cardlytics to its newly appointed Chief Financial Officer, David Evans. The restricted stock units were granted as a material inducement to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement P.

news source

Business Wire • Jan 16, 2026

news preview

Cardlytics (CDLX) Upgraded to Buy: Here's What You Should Know

Cardlytics (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news source

Zacks Investment Research • Jan 5, 2026

news preview

Cardlytics Appoints Company Alumnus David Evans as Chief Financial Officer

ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of David Evans as its new Chief Financial Officer, effective January 12, 2026. Evans is returning to Cardlytics, having previously held several executive roles including Chief Financial Officer and Chief Administrative Officer. As the returning Chief Financial Officer, Evans will oversee Cardlytics' finance, accounting, and investor relations functions as the company continues to execute against its longer-.

news source

Business Wire • Dec 18, 2025

news preview

All You Need to Know About Cardlytics (CDLX) Rating Upgrade to Buy

Cardlytics (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news source

Zacks Investment Research • Nov 10, 2025

news preview

Cardlytics, Inc. (CDLX) Q3 2025 Earnings Call Transcript

Cardlytics, Inc. ( CDLX ) Q3 2025 Earnings Call November 5, 2025 5:00 PM EST Company Participants Nick Lynton - Chief Legal & Privacy Officer and Secretary Amit Gupta - CEO & Director Alexis DeSieno - Chief Financial Officer Conference Call Participants Jacob Stephan - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Q3 2025 Cardlytics, Inc. Earnings Conference Call. [Operator Instructions] This call is being recorded on November 5, 2025.

news source

Seeking Alpha • Nov 6, 2025

news preview

Cardlytics Announces Third Quarter 2025 Financial Results

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the third quarter ended September 30, 2025. "In Q3, we've taken decisive action that we believe will reset our business, improve our financial health, and set ourselves on a viable path to return to growth," said Amit Gupta, CEO of Cardlytics. "We are moving forward with sharper focus and discipline, prioritizing initiatives that build on our fundamental strengths and wher.

news source

Business Wire • Nov 5, 2025

news preview

Cardlytics Announces Timing of Its Third Quarter 2025 Earnings Release

ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the third quarter ending September 30, 2025 will be released on November 5, 2025, after market close. Conference Call Details: When: November 5, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be availabl.

news source

Business Wire • Oct 22, 2025

news preview

Cardlytics Announces Workforce Reductions As Part Of Organizational Realignment and Cost Savings Initiative

ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced an enterprise-wide cost savings initiative aimed at optimizing its cost structure and aligning resources with its most critical business priorities. As part of this effort, Cardlytics reduced its workforce by approximately 120 full-time employees and contractors, representing about 30% of its total workforce. Cardlytics expects to incur $2.3 million in severance and related expenses in connection with this reduction, most.

news source

Business Wire • Oct 2, 2025

news preview

Cardlytics Repays 2020 Convertible Senior Notes Due 2025

ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the full and timely repayment of the remaining $46.1 million aggregate principal amount of its 1.00% convertible senior notes due on September 15, 2025. Following this repayment, Cardlytics now has $172.5 million aggregate principal amount outstanding of its 4.25% convertible senior notes due in 2029 and $50 million drawn on its line of credit. Cardlytics' cash and cash equivalents as of August 31, 2025 was $92.7 million a.

news source

Business Wire • Sep 15, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Cardlytics Inc.

Open an M1 investment account to buy and sell Cardlytics Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CDLX on M1